Abhishek (Abi) Agrawal

Senior Director for Strategic Initiatives and Market Development at GSK

Speaker

Abhishek (Abi) Agrawal is a biopharmaceutical strategy and business leader who sets enterprise direction and converts it into growth, operating at the intersection of corporate development, portfolio and asset valuation, and commercial execution.

He has executed oncology post-merger integration twice, Novartis-GSK in 2025 and GSK-Nuvalent in 2026. In senior U.S. commercial leadership at GSK and Novartis, he helped launch eight new molecular entities, led transformations of business units representing multibillion-dollar revenues (over 2K FTE), and owned launch strategy for KISQALI® and PIQRAY®, the latter exceeding forecast by 400 percent. He previously spent over a decade in consulting with IQVIA, Strategic Decisions Group, and BIONEST.

Abhishek advises the Alzheimer’s Drug Discovery Foundation (Diagnostic), and NYU’s deep-tech incubator. He holds a Master’s in Bioscience from Claremont Graduate University and a B.S. from Coastal Carolina University, where he graduated valedictorian.